EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Pulmonary invasive mucinous adenocarcinoma

Wei-Chin Chang iD, Yu Zhi Zhang, Andrew G Nicholson iD

Histopathology · 2024-01 · 84 (1) · 18-31

DOI: 10.1111/his.15064 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 22.10.2023. Verfasst von Wei-Chin Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Adenocarcinoma, Mucinous, Adenocarcinoma. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive mucinous adenocarcinoma (IMA) is a relatively rare subtype of lung adenocarcinoma, composed of goblet and/or columnar tumour cells containing abundant intracytoplasmic mucin vacuoles. While a majority of IMAs are driven by KRAS mutations, recent studies have identified distinct genomic alterations, such as NRG1 and ERBB2 fusions. IMAs also more frequently present as a pneumonic‐like pattern with multifocal and multilobar involvement, and comparative genomic profiling predominantly shows a clonal relationship, suggesting intrapulmonary metastases rather than synchronous primary tumours. Accordingly, these unique features require different therapeutic approaches when compared to nonmucinous adenocarcinomas in general. In this article, we review recent updates on the histopathological, clinical, and molecular features of IMAs, and also highlight some unresolved issues for future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungAdenocarcinoma, MucinousAdenocarcinomaHumansMutation

Stichwörter der Autor:innen

ERBB2KRASNRG1congenital pulmonary airway malformationinvasive mucinous adenocarcinomalung adenocarcinoma

Autor:innen und Institutionen

  • Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan.
  • Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • National Heart and Lung Institute, Imperial College, London, UK.

ORCID-Profile: Wei-Chin Chang, Andrew G Nicholson

Zitieren

APA

Chang, W. C., Zhang, Y. Z., & Nicholson, A. G. (2024). Pulmonary invasive mucinous adenocarcinoma. Histopathology, 84(1), 18-31. https://doi.org/10.1111/his.15064

Vancouver

Chang WC, Zhang YZ, Nicholson AG. Pulmonary invasive mucinous adenocarcinoma. Histopathology. 2024;84(1):18-31. doi:10.1111/his.15064

BibTeX
@article{Chang2024,
  author = {Chang, Wei-Chin and Zhang, Yu Zhi and Nicholson, Andrew G},
  title = {Pulmonary invasive mucinous adenocarcinoma},
  journal = {Histopathology},
  year = {2024},
  volume = {84},
  number = {1},
  pages = {18--31},
  doi = {10.1111/his.15064}
}
Kostenlos starten →